From the inbox:
At Schrödinger our mission is to revolutionize drug discovery through the use of breakthrough computational methods. The latest advances in our technology allow us to identify high quality lead compounds and efficiently optimize them for clinical development. Our drug discovery team of 20+ scientists includes designers, modelers, computational chemists, medicinal chemists, crystallographers, biochemists, and biologists with well over 100 years of drug discovery experience.
The drug discovery team is supported by more than 100 software developers. Three of the programs we’ve worked on in the past 5 years have progressed into the clinic and an additional one is expected to enter trials later in the year. Members of the drug discovery group are included as inventors on more than 40 US patents and patent applications filed by our collaborators. As our group continues to grow, we are looking for highly motivated individuals with experience designing drug candidates in 3D.
Responsibilities:
Play a key role in our drug discovery projects
Design molecules to meet project goals
Work closely with collaborators and other members of the drug discovery group to drive programs and our technology forward
Essential Qualifications and Experience:
Ability to design compounds in a 3D structure-based environment
Understanding of protein-ligand interactions and small molecule conformations, ionization, and tautomeric states
Ph.D. in organic or medicinal chemistry
Modeling experience
Exceptional communication skills
Desirable Skills:
Practical understanding of the application of physical organic chemistry principles to drug discovery
Computational chemistry experience
Interested candidates can apply through our website at: http://www.schrodinger.com/careers/description/203
Schrödinger, Inc. is an equal opportunity employer.Best wishes to those interested!
No comments:
Post a Comment
looks like Blogger doesn't work with anonymous comments from Chrome browsers at the moment - works in Microsoft Edge, or from Chrome with a Blogger account - sorry! CJ 3/21/20